share

4-(6,8-Dioxo-5,8-Dihydro[1,3]Dioxolo[4,5-G]Quinazolin-7(6H)-Yl)Butanoicacid CAS NO 892293-14-0


Unit Price:

CAS No.:892293-14-0

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

4-(6,8-Dioxo-5,8-Dihydro[1,3]Dioxolo[4,5-G]Quinazolin-7(6H)-Yl)Butanoicacid is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is critical for the synthesis of novel active pharmaceutical ingredients (APIs) targeting specific therapeutic pathways. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of innovative small-molecule drugs.

Application

  • Pharmaceutical Intermediate: Key building block in the synthesis of novel quinazoline-based active pharmaceutical ingredients (APIs).
  • Drug Discovery & Development: Used in medicinal chemistry research for lead optimization and the creation of new chemical entities (NCEs).
  • Biochemical Research: Serves as a precursor or reference standard in studies of enzyme inhibition and receptor binding assays.
  • Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects.
  • Academic Research: Employed in university and institutional labs for heterocyclic chemistry and synthetic methodology studies.

Basic Information

Product Name 4-(6,8-Dioxo-5,8-Dihydro[1,3]Dioxolo[4,5-G]Quinazolin-7(6H)-Yl)Butanoicacid
CAS No. 892293-14-0
Molecular Formula C15H12N2O6
Molecular Weight 316.27 g/mol
Synonyms 4-(6,8-Dioxo-5,8-dihydro-[1,3]dioxolo[4,5-g]quinazolin-7(6H)-yl)butanoic acid; 7-(3-Carboxypropyl)-5,8-dihydro-6H-[1,3]dioxolo[4,5-g]quinazoline-6,8-dione; Butanoic acid, 4-(6,8-dioxo-5,8-dihydro[1,3]dioxolo[4,5-g]quinazolin-7(6H)-yl)-; 892293-14-0; [1,3]Dioxolo[4,5-g]quinazoline-7(6H)-butanoic acid derivative
EINECS Contact for details

Quality Control

Our 4-(6,8-Dioxo-5,8-Dihydro[1,3]Dioxolo[4,5-G]Quinazolin-7(6H)-Yl)Butanoicacid is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D and manufacturing. Certificates of Analysis (COA) with detailed chromatographic data are provided for full traceability and compliance.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after each use to prevent degradation from atmospheric moisture.

Specification

Item Specification
Appearance Off-white to light yellow powder
Identification (IR) Conforms to structure
Purity (HPLC) ≥ 98.0%
Loss on Drying ≤ 1.0%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.